The strong results of KEYNOTE-689 and likely FDA approval of pembrolizumab for perioperative HNSCC raise both concerns and ...

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Neurocrine Biosciences shares catapulted Tuesday on "surprising commercial momentum" for its newest drug, Crenessity.

Gov. Andy Beshear and health officials announced Tuesday that overdose deaths dropped by more than 30% in 2024 compared to ...

Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...

The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the treatment of hypertension in adults, to lower blood pressure.

Krystal Biotech KRYS reported first-quarter 2025 earnings per share (EPS) of $1.20, which missed the Zacks Consensus Estimate ...

Nine months cancer-free, Tiffiney Beard never missed a day of work during her three-month treatment with the new proton ...

Narsoplimab is a human monoclonal antibody that specifically targets mannan-binding lectin-associated serine protease-2.

The FDA has approved Johnson & Johnson’s drug Imaavy for the treatment of generalized myasthenia gravis, a chronic autoimmune neuromuscular disorder. The approval covers adults and pediatric patients ...

With the clinical hold on the tab-cel application lifted, phase 2 and 3 trials of the T-cell immunotherapy in patients with ...

Albuquerque City Councilors approved a resolution to use Opioid Settlement Funds to build a new Sobering Center as part of the Gateway system. The money is part of an $80 million package the city ...